Key facts
- This page summarizes Hugh Mccoll III's Form 3 filing for MIRA PHARMACEUTICALS, INC. (MIRA).
- 0 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 02 Aug 2023, 18:00.
Hugh Mccoll III - 02 Aug 2023 Form 3 Insider Report for MIRA PHARMACEUTICALS, INC. (MIRA)
- Reporting relationship
- Director
- Issuer ticker
- MIRA
- Reported as of
- 02 Aug 2023
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 02 Aug 2023, 18:00:51 UTC
- Prior SEC filing
- 29 Aug 2022
- Next SEC filing
- 16 Aug 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michelle Yanez, Attorney-in-Fact for Hugh McColl, III
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Hugh Mccoll III filed Form 3 for MIRA PHARMACEUTICALS, INC. (MIRA) on 02 Aug 2023.
Change
- Previous filing in this sequence was filed on 29 Aug 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MIRA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 40,000
- Date
- 02 Aug 2023
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MIRA
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 02 Aug 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,000
- Exercise price
- $5.00
- Footnotes
- F1
MIRA
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 02 Aug 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,000
- Exercise price
- $5.00
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The option vested and became exercisable in full on June 15, 2022.
Footnote F2
The option vested and became exercisable in full on April 28, 2023.